QNRX
QNRX
Positions held
Your positionsQNRX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$5.4M | -$5.0M | -$4.3M | -$3.9M | -$3.7M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$5.5M | -$5.1M | -$4.5M | -$4.0M | -$3.8M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$15.8M | -$9.0M | -$8.7M | -$9.4M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$16.3M | -$9.5M | -$9.4M | -$9.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
2026-09-22 · Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
2026-09-08 · Quoin in line for priority review voucher if rare paediatric drug approved
2026-09-08 · Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
2026-08-28 · Sector Update: Healthcare Stocks Decline Friday Afternoon
2026-08-28 · Top Midday Gainers
2026-08-28 · Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome
2026-08-28 · Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
2026-08-27 · QNRX: Believe Conditional FDA Approval of Proposed Brand Name Reflects QRX003 Nearing Potential Commercialization
2026-08-14 · Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Price (daily)
Full chart · RSI · MACD · patterns